Identification of a Racially Dimorphic Variant in the Human Platelet PAR4 Thrombin Receptor Altering Platelet Function and Pharmacologic Inhibition

被引：0
|
作者：
Edelstein, Leonard C. [1 ]
Simon, Lukas M. [2 ]
Lindsay, Cory R. [1 ]
Kong, Xiango [1 ]
Montoya, Raul Teruel [1 ]
Tourdot, Benjamin E. [1 ]
Chen, Edward [2 ]
Ma, Lin [1 ]
Coughlin, Shaun R. [3 ]
Nieman, Marvin T. [4 ]
Holinstat, Michael [1 ]
Shaw, Chad [2 ]
Bray, Paul F. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] UCSF, San Francisco, CA USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Bivalirudin Effects on Thrombin Do Not Significantly Alter Platelet Activation Through the Thrombin Receptors Par1 and Par4
    Holinstat, Michael
    Hudson, W. J.
    Cleator, John H.
    Hamm, Heidi E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E122 - E122
  • [22] Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
    Ramachandran, Rithwik
    Mihara, Koichiro
    Thibeault, Pierre
    Vanderboor, Christina M.
    Petri, Bjorn
    Saifeddine, Mahmoud
    Bouvier, Michel
    Hollenberg, Morley D.
    MOLECULAR PHARMACOLOGY, 2017, 91 (04) : 287 - U230
  • [23] PAR1, but not PAR4, regulates human platelet activation through PLD
    Holinstat, M
    Voss, B
    Bilodeau, ML
    Hamm, HE
    FASEB JOURNAL, 2006, 20 (04): : A695 - A696
  • [24] Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
    Vretenbrant, Karin
    Ramstrom, Sofia
    Bjerke, Maria
    Lindahl, Tomas L.
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (03) : 417 - 424
  • [25] Thrombin-induced platelet activation via PAR4: pivotal role for exosite II
    Boknas, Niklas
    Faxalv, Lars
    Centellas, Daniel Sanchez
    Wallstedt, Maria
    Ramstrom, Sofia
    Grenegard, Magnus
    Lindahl, Tomas L.
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (03) : 558 - 565
  • [26] Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin
    Jan Julius Stampfuss
    Karsten Schrör
    Artur-Aron Weber
    Nature Medicine, 2003, 9 : 1447 - 1447
  • [27] PAR4 Ala120Thr Variant Alters PAR4 Desensitization, Sensitivity to Platelet Antagonists and Risk of Large Vessel Stroke
    Whitley, Michael
    Henke, David
    Simon, Lukas
    Vesci, Joanne
    Holinstat, Michael
    Nieman, Marvin
    Shaw, Chad
    Bray, Paul
    Edelstein, Leonard
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [28] Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog
    Lin, Yu-Chuan
    Ko, Yen-Chun
    Hung, Shang-Cheng
    Lin, Ying-Ting
    Lee, Jia-Hau
    Tsai, Ju-Ying
    Kung, Po-Hsiung
    Tsai, Meng-Chun
    Chen, Yih-Fung
    Wu, Chin-Chung
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (04) : 694 - 703
  • [29] Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4
    Kaplan, Zane S.
    Zarpellon, Alessandro
    Alwis, Imala
    Yuan, Yuping
    McFadyen, James
    Ghasemzadeh, Mehran
    Schoenwaelder, Simone M.
    Ruggeri, Zaverio M.
    Jackson, Shaun P.
    NATURE COMMUNICATIONS, 2015, 6
  • [30] Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4
    Zane S. Kaplan
    Alessandro Zarpellon
    Imala Alwis
    Yuping Yuan
    James McFadyen
    Mehran Ghasemzadeh
    Simone M. Schoenwaelder
    Zaverio M. Ruggeri
    Shaun P. Jackson
    Nature Communications, 6
12345